搜索临床试验以:Stenting of the Common and/or External Iliac Arteries
总计448个结果
-
Memorial Sloan Kettering Cancer Center完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的
-
Hospital de Clinicas de Porto Alegre完全的
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)终止
-
Novartis Pharmaceuticals完全的
-
State University of New York - Upstate Medical...CTI BioPharma完全的
-
Tan Tock Seng HospitalMelbourne Health; National University Hospital, Singapore; Samsung Medical Center; University of... 和其他合作者招聘中
-
Novartis Pharmaceuticals完全的乳腺癌印度, 马来西亚, 沙特阿拉伯, 台湾, 俄罗斯联邦, 黎巴嫩, 南非, 泰国, 约旦, 火鸡, 埃及, 越南, 新加坡
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)完全的
-
University of California, San DiegoNational Institute on Drug Abuse (NIDA)完全的
-
University of Manitoba完全的
-
University of Western Ontario, CanadaPfizer完全的
-
Benaroya Research InstituteVirginia Mason Hospital/Medical Center招聘中
-
Santiago Garcia-Hernandez完全的
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp & Dohme LLC; Janssen... 和其他合作者终止
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey Clinic完全的
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)完全的
-
Rafa LaboratoriesTeva Branded Pharmaceutical Products R&D, Inc.终止
-
U.S. Army Medical Research and Development CommandMilitary Infectious Diseases Research Program (MIDRP)完全的
-
University Hospital, AkershusVestre Viken Hospital Trust; University of Oslo; Asker & Baerum Hospital; Sykehuset Innlandet HF未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中化疗毒性 | 放射治疗;并发症 | PARP抑制剂 | 免疫检查点抑制剂 | 曲妥珠单抗 | 乳腺癌,家族性男性 | CDK4/6 抑制剂 | 帕妥珠单抗中国
-
University Health Network, Toronto尚未招聘
-
University of Alabama at BirminghamCongressionally Directed Medical Research Programs完全的